<?xml version="1.0" encoding="UTF-8"?><faers xmlns="http://fda.gov/ns/faers"><meta><status>PENDING</status><version>v2</version><patient-age/><report-id>US-PFIZER INC-2013007834</report-id><gender>male</gender><reactions><reaction>He ruptured his right quadriceps tendon</reaction></reactions><drugs><drug><ndc>59572983</ndc><drug-name>Lipitor</drug-name><manufacturer/><ingredients/></drug></drugs><indications><indication>Blood cholesterol increased</indication></indications><outcomes/><country>United States</country><geo/></meta><original><ichicsr lang="en" xmlns="">
	<ichicsrmessageheader>
		<messagetype>psur</messagetype>
		<messageformatversion>2.1</messageformatversion>
		<messageformatrelease>2.0</messageformatrelease>
		<messagenumb>4254112_P31</messagenumb>
		<messagesenderidentifier>PFIZERINC</messagesenderidentifier>
		<messagereceiveridentifier>ZZFDA</messagereceiveridentifier>
		<messagedateformat>204</messagedateformat>
		<messagedate>20130125151548</messagedate>
	</ichicsrmessageheader>
	<safetyreport>
		<safetyreportversion>2</safetyreportversion>
		<safetyreportid>US-PFIZER INC-2013007834</safetyreportid>
		<primarysourcecountry>US</primarysourcecountry>
		<occurcountry>US</occurcountry>
		<transmissiondateformat>102</transmissiondateformat>
		<transmissiondate>2013-01-25</transmissiondate>
		<reporttype>1</reporttype>
		<serious code="1">Yes</serious>
		<seriousnessdeath>2</seriousnessdeath>
		<seriousnesslifethreatening>2</seriousnesslifethreatening>
		<seriousnesshospitalization>2</seriousnesshospitalization>
		<seriousnessdisabling>2</seriousnessdisabling>
		<seriousnesscongenitalanomali>2</seriousnesscongenitalanomali>
		<seriousnessother>1</seriousnessother>
		<receivedateformat>102</receivedateformat>
		<receivedate>2013-01-07</receivedate>
		<receiptdateformat>102</receiptdateformat>
		<receiptdate>2013-01-22</receiptdate>
		<additionaldocument>2</additionaldocument>
		<fulfillexpeditecriteria>2</fulfillexpeditecriteria>
		<companynumb>US-PFIZER INC-2013007834</companynumb>
		<medicallyconfirm>1</medicallyconfirm>
		<primarysource>
			<reportertitle>Dr.</reportertitle>
			<reportergivename>Thomas</reportergivename>
			<reportermiddlename>M</reportermiddlename>
			<reporterfamilyname>Blum</reporterfamilyname>
			<reporterorganization>Mystic Medical group</reporterorganization>
			<reporterstreet>200 Sandy Hollow Road</reporterstreet>
			<reportercity>Mystic</reportercity>
			<reporterstate>CT</reporterstate>
			<reporterpostcode>06355</reporterpostcode>
			<reportercountry>US</reportercountry>
			<qualification code="1">Physician</qualification>
		</primarysource>
		<primarysource>
			<reportergivename>Theresa</reportergivename>
			<reportermiddlename>C</reportermiddlename>
			<reporterfamilyname>Wilson</reporterfamilyname>
			<reporterorganization>Pfizer</reporterorganization>
			<reporterdepartment>NCE PDM ADME CoE</reporterdepartment>
			<reportercountry>US</reportercountry>
			<qualification code="5">Consumer or non-health professional</qualification>
		</primarysource>
		<sender>
			<sendertype>1</sendertype>
			<senderorganization>PFIZERINC</senderorganization>
			<senderfamilyname>Head Drug Safety Surveillance</senderfamilyname>
			<senderstreetaddress>150 East 42nd Street</senderstreetaddress>
			<sendercity>New York</sendercity>
			<senderstate>New York</senderstate>
			<senderpostcode>10017</senderpostcode>
			<sendercountrycode>US</sendercountrycode>
			<sendertel>2127335544</sendertel>
		</sender>
		<receiver>
			<receivertype>2</receivertype>
			<receiverorganization>ZZFDA</receiverorganization>
			<receivertitle>Mr</receivertitle>
			<receivergivename>Roger</receivergivename>
			<receiverfamilyname>Goetsch</receiverfamilyname>
			<receiverstreetaddress>8201 Corporate Drive, Suite 540</receiverstreetaddress>
			<receivercity>Landover</receivercity>
			<receiverstate>MD</receiverstate>
			<receiverpostcode>20785</receiverpostcode>
			<receivercountrycode>US</receivercountrycode>
			<receivertel>3019189580</receivertel>
			<receivertelextension>194</receivertelextension>
			<receivertelcountrycode>001</receivertelcountrycode>
			<receiverfax>3019183134</receiverfax>
			<receiverfaxcountrycode>001</receiverfaxcountrycode>
		</receiver>
		<patient>
			<patientinitial>PRIVACY</patientinitial>
			<patientsex code="1">Male</patientsex>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Tendon rupture</patientepisodename>
				<patientmedicalcomment>while on Lipitor</patientmedicalcomment>
			</medicalhistoryepisode>
			<reaction>
				<primarysourcereaction>He ruptured his right quadriceps tendon</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Tendon rupture</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Tendon rupture</reactionmeddrapt>
				<reactionstartdateformat>602</reactionstartdateformat>
				<reactionstartdate>2011</reactionstartdate>
				<reactionoutcome code="1">recovered/resolved</reactionoutcome>
			</reaction>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>Lipitor</medicinalproduct>
				<obtaindrugcountry>US</obtaindrugcountry>
				<drugauthorizationnumb>20-702</drugauthorizationnumb>
				<drugauthorizationcountry>US</drugauthorizationcountry>
				<drugauthorizationholder>Pfizer, Inc.</drugauthorizationholder>
				<drugstructuredosagenumb>10</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugseparatedosagenumb>1</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugdosagetext>10 mg, Daily</drugdosagetext>
				<drugdosageform normalized="film-coated tablet">Film-coated tablet</drugdosageform>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Blood cholesterol increased</drugindication>
				<drugstartdateformat>602</drugstartdateformat>
				<drugstartdate>2006</drugstartdate>
				<actiondrug code="4">Dose not changed</actiondrug>
				<activesubstance>
					<activesubstancename>ATORVASTATIN CALCIUM</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Tendon rupture</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>N/A</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Tendon rupture</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>N/A</drugresult>
				</drugreactionrelatedness>
			</drug>
			<summary>
				<narrativeincludeclinical>This is a spontaneous report initially from a contactable consumer, a Pfizer employee (patient's wife) and then from a contactable <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician</Semaphore>. A male patient of an unspecified age and ethnicity started to receive <Semaphore x="169912" class="Medicine" value="Atorvastatin calcium" score="0.93" ID="286842">atorvastatin <Semaphore x="1670132" class="Procedure" value="Calcium Measurement" score="1.00" ID="C64488">calcium </Semaphore></Semaphore>(<Semaphore x="791535" class="Medicine" value="Lipitor" score="0.74" ID="239689">LIPITOR</Semaphore>) <Semaphore x="2336704" class="AnatomicStructure" value="Oral Cavity" score="1.00" ID="C12421">oral </Semaphore>from 2006 with duration of <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">treatment </Semaphore>of 7 years and ongoing (initially reported from 20 years ago) at 10 mg, daily for increased <Semaphore x="1772951" class="Procedure" value="Cholesterol Measurement" score="1.00" ID="C105586">cholesterol</Semaphore>. Medical history included that the patient ruptured left quad <Semaphore x="2605201" class="AnatomicStructure" value="Tendon Sheath" score="1.00" ID="C96299">tendon </Semaphore>while on <Semaphore x="169912" class="Medicine" value="Atorvastatin calcium" score="0.93" ID="286842">atorvastatin <Semaphore x="1670132" class="Procedure" value="Calcium Measurement" score="1.00" ID="C64488">calcium </Semaphore></Semaphore>(trade name <Semaphore x="791535" class="Medicine" value="Lipitor" score="0.74" ID="239689">LIPITOR</Semaphore>) on an unknown date. There were no drug <Semaphore x="1470824" class="Disease or Finding" value="Allergic Reaction" score="1.00" ID="C114476">allergies </Semaphore>and family history. There were no concomitant medications and relevant <Semaphore x="1670730" class="Procedure" value="CAM Pharmacological or Biological Treatment" score="1.00" ID="C15906">drug </Semaphore>history. The patient <Semaphore x="3271631" class="MedDRA LLT" value="Tendon rupture" score="1.00" ID="10043248"><Semaphore x="2473082" class="Disease or Finding" value="Rupture" score="1.00" ID="C9445">ruptured </Semaphore>his right quadriceps <Semaphore x="2605201" class="AnatomicStructure" value="Tendon Sheath" score="1.00" ID="C96299">tendon </Semaphore></Semaphore>in 2011. The action taken in <Semaphore x="1854566" class="Disease or Finding" value="Disease Response" score="1.00" ID="C50995">response </Semaphore>to the event for <Semaphore x="169912" class="Medicine" value="Atorvastatin calcium" score="0.93" ID="286842">atorvastatin <Semaphore x="1670132" class="Procedure" value="Calcium Measurement" score="1.00" ID="C64488">calcium </Semaphore></Semaphore>was <Semaphore x="1863447" class="Procedure" value="Dose Not Changed" score="1.00" ID="C49504">dose not changed</Semaphore>. In the <Semaphore x="1938518" class="Disease or Finding" value="First-Degree Burn" score="1.00" ID="C76130">initial </Semaphore>report, it was reported that the patient attended a <Semaphore x="2419635" class="Procedure" value="Preoperative Chemotherapy" score="1.00" ID="C68770">pre operative </Semaphore>visit on 07Jan2013 to <Semaphore x="2328864" class="Disease or Finding" value="Obtundation" score="1.00" ID="C28209">obtain </Semaphore>clearance for <Semaphore x="2596409" class="Procedure" value="Surgical Procedure" score="1.00" ID="C15329">surgery </Semaphore>to repair the ruptured quadriceps <Semaphore x="2605201" class="AnatomicStructure" value="Tendon Sheath" score="1.00" ID="C96299">tendon </Semaphore>in his left <Semaphore x="2104605" class="AnatomicStructure" value="Leg" score="1.00" ID="C32974">leg</Semaphore>. His <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician </Semaphore>informed him that <Semaphore x="2605201" class="AnatomicStructure" value="Tendon Sheath" score="1.00" ID="C96299">tendon </Semaphore><Semaphore x="2473082" class="Disease or Finding" value="Rupture" score="1.00" ID="C9445">rupture </Semaphore>was a <Semaphore x="2520673" class="Disease or Finding" value="Side Effect" score="1.00" ID="C2861">side effect </Semaphore>of <Semaphore x="169912" class="Medicine" value="Atorvastatin calcium" score="0.93" ID="286842">atorvastatin <Semaphore x="1670132" class="Procedure" value="Calcium Measurement" score="1.00" ID="C64488">calcium </Semaphore></Semaphore>and decided to pull him off it. In the further report the <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician </Semaphore>confirmed that therapeutic measures taken as a <Semaphore x="1910095" class="Disease or Finding" value="Experimental Result" score="1.00" ID="C76125">result </Semaphore>of was <Semaphore x="2596409" class="Procedure" value="Surgical Procedure" score="1.00" ID="C15329">surgical </Semaphore>repair. The <Semaphore x="2353201" class="Disease or Finding" value="Outcome" score="1.00" ID="C20200">outcome </Semaphore>of the event was recovered. In the report as of 22Jan2013, the <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician </Semaphore>confirmed the occurrence of the event reported and assessed there was a reasonable possibility that the event was related to suspect product.Follow up (22Jan2013): New information received from a contactable <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician </Semaphore>includes: product detail data, relevant medical history, concomitant medications data, event onset date, action taken data, <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">treatment </Semaphore>data, event <Semaphore x="2353201" class="Disease or Finding" value="Outcome" score="1.00" ID="C20200">outcome </Semaphore>and causality <Semaphore x="2397639" class="Procedure" value="Physical Examination" score="1.00" ID="C20989">assessment </Semaphore>of the <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician</Semaphore>.Follow up attempts completed. No further information expected.</narrativeincludeclinical>
				<sendercomment>Based on available information, a possible contributory role of the subject drug can not be excluded for the reported event.</sendercomment>
			</summary>
		</patient>
	</safetyreport>
</ichicsr></original></faers>